Advertisement.
Advertisement.
Advertisement
Advertisement.
BPTS Biophytis SA ADR
881
| Market Cap | $3.52M |
| Volume | 12.00 |
| 52-Wk High | $82.40 |
| 52-Wk Low | $5.44 |
Why Is Penny Stock Biophytis Trading Higher On Tuesday?
Benzinga•4 months ago
Announcing OBA clinical development program by Biophytis with BIO101 (20-hydroxyecdysone) for obesity treatment. Phase 2 study expected mid-2024, with efficacy results anticipated in 2025.
read more...
Share to Feed
Gagnants
Le titre Acrivon Therapeutics (NASDAQ:ACRV) a mont mardi de 75,12% 10,35 dollars lors de la session pre-market.
Le titre Biophytis (NASDAQ:BPTS) a augment de 40,48% 0,45 dollars.
Le...
Benzinga•4 months ago
Shares of Biophytis S.A. (NASDAQ: BPTS) rose sharply in today's pre-market trading after reporting FY23 results.
read more...
Benzinga•4 months ago
All resolutions presented by the Company have been adoptedPARIS, FRANCE AND CAMBRIDGE, MA / ACCESSWIRE / April 4, 2024 / Biophytis SA (NASDAQ:BPTS),(Euronext Growth Paris:ALBPS), ('Biophytis' or the...
Accesswire•4 months ago
Biophytis S.A. (NASDAQ:BPTS - Get Free Report) was the target of a significant growth in short interest in the month of March. As of March 15th, there was short interest totalling 42,900 shares, a...
Ticker Report•4 months ago
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Novartis AG (CH:NOVN Research Report) and Biophytis SA...
TipRanks Financial Blog•4 months ago
PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / March 22, 2024 / Biophytis SA (Nasdaq:BPTS)(Euronext Growth Paris:ALBPS), ('Biophytis' or the 'Company'), a clinical-stage biotechnology company...
Accesswire•4 months ago